Increased mortality among elderly patients with dementia using atypical antipsychotics

Singh, Sonal; Wooltorton, Eric
August 2005
CMAJ: Canadian Medical Association Journal;8/2/2005, Vol. 173 Issue 3, p252
Academic Journal
Discusses research being done on the use of atypical anti-psychotic drugs in the treatment of behavioral and psychological symptoms of dementia. Reference to a study by P. E. Lee, S. S. Freedman et al, published in the 2004 issue of the "British Medical Journal"; Incidence of death among elderly patients with dementia in studies of three atypical anti-psychotics; Management of behavioral disturbances in advanced dementia.


Related Articles

  • Review: Limited evidence supports the use of atypical antipsychotic drugs in behavioral and psychological symptoms of dementia. Lee, P. // ACP Journal Club;Jan/Feb2005, Vol. 142 Issue 1, p15 

    The article reports that limited evidence supports the use of atypical antipsychotic drugs in behavioral and psychological symptoms of dementia. Efficacy was assessed by scores on the Behavior pathology in Alzheimer s Disease, Cohen-Mansfield Agitation Inventory and Neuropsychiatrie...

  • Antipsychotics.  // Reactions Weekly;Mar2014, Vol. 1493 Issue 1, p10 

    The article presents case studies of six women and seven men who developed neuroleptic malignant syndrome while receiving treatment with antipsychotics. It is reported that the patients were receiving treatment for schizophrenia, affective disorders, organic mental disorder or disorder of adult...

  • Antipsychotic Use in Individuals With Dementia: An Overview for Policymakers. Carnahan, Ryan M.; Kelly, Michael W.; Smith, Marianne // Public Policy & Aging Report; 

    The article provides an overview of antipsychotic use in individuals with dementia which can be of importance to U.S. policymakers. It discusses the findings of a 2011 report on atypical antipsychotic use in nursing home residents from January 1, 2007 through June 30, 2007. It also looks at...

  • Ethical dilimmas: should antipsychotics ever be prescribed for people with dementia? Treloar, Adrian; Crugel, Monica; Prasanna, Aparna; Solomons, Luke; Fox, Chris; Paton, Carol; Katona, Cornelius // British Journal of Psychiatry;Aug2010, Vol. 197 Issue 2, p88 

    The use of antipsychotics for the treatment of behavioural and psychological symptoms of dementia (BPSD) is controversial. Antipsychotics cause harm and evidence-based guidelines advise against their use. We argue that antipsychotics may be justified using a palliative model: by reducing severe...

  • THE BITTEREST PILLS: THE TROUBLING STORY OF ANTIPSYCHOTIC DRUGS. Johnson, Shaun // Mental Health Today;Nov/Dec2014, p30 

    No abstract available.

  • ACNP White Paper: Update on Use of Antipsychotic Drugs in Elderly Persons with Dementia. Jeste, Dilip V.; Blazer, Dan; Casey, Daniel; Meeks, Thomas; Salzman, Carl; Schneider, Lon; Tariot, Pierre; Yaffe, Kristine // Neuropsychopharmacology;May2008, Vol. 33 Issue 6, p957 

    In elderly persons, antipsychotic drugs are clinically prescribed off-label for a number of disorders outside of their Food and Drug Administration (FDA)-approved indications (schizophrenia and bipolar disorder). The largest number of antipsychotic prescriptions in older adults is for behavioral...

  • Antipsychotic dosing: found in translation. Remington, Gary; Fervaha, Gagan; Foussias, George; Agid, Ofer; Turrone, Peter // Journal of Psychiatry & Neuroscience;Jul2014, Vol. 39 Issue 4, p223 

    In the field of schizophrenia research, as in other areas of psychiatry, there is a sense of frustration that greater advances have not been made over the years, calling into question existing research strategies. Arguably, many purported gains claimed by research have been "lost in...

  • Case Histories Illustrating the Utility of Sertindole in Clinical Practice. Schuck, Peter; Ameele, Hans van den; Jaanson, Peeter; Ryckmans, Vincent; Hawley, Chris // CNS Drugs;2004 Supplement 2, Vol. 18, p31 

    Many conventional and atypical antipsychotic agents are available for the treatment of schizophrenia. Matching individual patients to the medication that suits them best is often a matter of trial and error. Controlled clinical trials and extensive post-marketing research have shown that the...

  • Blockade of 5-HT2a Receptors Reduces Haloperidol-Induced Attenuation of Reward. Benaliouad, Faïza; Kapur, Shitij; Rompré, Pierre-Paul // Neuropsychopharmacology;Mar2007, Vol. 32 Issue 3, p551 

    Previous studies have shown that effective antipsychotic medications attenuate reward, an effect that is generally attributed to their effectiveness at blocking the dopamine D2-like receptors. As blockade of the serotonin type 2a (5-HT2a) receptors is a common property of the newer...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics